Killing tumor cells with viruses—a question of specificity

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Nature Medicine

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/2000PMID 9734392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen Receptor Activation in Prostatic Tumor Cell Lines by Insulin-like Growth Factor-I, Keratinocyte Growth Factor, and Epidermal Growth Factor1

  2006cited by this paper
• Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

  1998cited by this paper
• p53-dependent cell death/apoptosis is required for a productive adenovirus infection

  1998influential reference
• Elevated expression of caveolin is associated with prostate and breast cancer.

  1998cited by this paper
• Endothelin attenuates apoptosis in human smooth muscle cells.

  1997cited by this paper
• ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

  1997cited by this paper
• Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor

  1996cited by this paper
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

  1996cited by this paper
• Reduction of caveolin and caveolae in oncogenically transformed cells.

  1995cited by this paper
• Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate

  1995cited by this paper
• In vivo amplification of the androgen receptor gene and progression of human prostate cancer

  1995cited by this paper
• Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor.

  1995cited by this paper
• Implication of cell kinetic changes during the progression of human prostatic cancer.

  1995cited by this paper
• Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin.

  1994cited by this paper
• Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease

  1994cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

  1992cited by this paper
• Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection.

  1987cited by this paper
• Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.

  1982cited by this paper
• THE FINE STRUCTURE OF THE GALL BLADDER EPITHELIUM OF THE MOUSE

  1955cited by this paper

• Correlation of p53 Expression with Different Histological Grades in Oral Squamous Cell Carcinoma Patients from Northern India

  2018cites this paper
• Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation.

  2012cites this paper
• [Dominant negative activity of mutated p53 proteins].

  2006cites this paper
• Activité dominante négative des protéines p53 mutées

  2006cites this paper
• Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells.

  2004cites this paper
• Human papillomavirus therapy for the prevention and treatment of cervical cancer

  2003cites this paper
• Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus

  2002cites this paper
• Gene therapy for liver metastases.

  2002cites this paper
• Adenoviral gene therapy.

  2002cites this paper
• Exploiting genetic alterations to design novel therapies for cancer.

  2001cites this paper
• Oncolytic viruses and cancer therapy.

  2001cites this paper
• E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver Tumors

  2001cites this paper
• Strategies for manipulating the p53 pathway in the treatment of human cancer

  2000cites this paper
• The role of a surgeon in a palliative treatment of tumours.

  2000cites this paper
• The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.

  2000cites this paper
• XVIII. Petřivalský - Rapant Day

  2000cites this paper
• Strategies for manipulating the p53 pathway in the treatment of human cancer.

  2000cites this paper
• Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression

  2000cites this paper
• p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication

  1999cites this paper
• p53-oriented cancer therapies: current progress.

  1999cites this paper
• New treatment strategies for malignant gliomas.

  1999cites this paper
• Exploiting the p53 pathway for cancer diagnosis and therapy.

  1999cites this paper
• Corepressor Required for Adenovirus E1B 55,000-Molecular-Weight Protein Repression of Basal Transcription

  1999cites this paper
• p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication

  1999cites this paper
• Reply to “Chaos in cancer?”

  1998cites this paper
• Chaos in cancer?

  1998cites this paper
• ONYX-015: Clinical data are encouraging

  1998cites this paper